These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1355 related items for PubMed ID: 12797703

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of combined therapy of oral anti-tubercular agents on theophylline pharmacokinetics.
    Ahn HC, Yang JH, Lee HB, Rhee YK, Lee YC.
    Int J Tuberc Lung Dis; 2000 Aug; 4(8):784-7. PubMed ID: 10949332
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 6. The short-term effects of anti-tuberculosis therapy on plasma pyridoxine levels in patients with pulmonary tuberculosis.
    Visser ME, Texeira-Swiegelaar C, Maartens G.
    Int J Tuberc Lung Dis; 2004 Feb; 8(2):260-2. PubMed ID: 15139457
    [Abstract] [Full Text] [Related]

  • 7. [Standardized controlled antitubercular therapy and results in 755 patients].
    Wiesner B, Cramer G, Hamel U, Roth G.
    Z Erkr Atmungsorgane; 1991 Feb; 177(1-2):71-5. PubMed ID: 1808855
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
    Smirnova TG, Chernousova LN, Andreevskaia SN, Nikolaeva GM.
    Probl Tuberk Bolezn Legk; 2004 Feb; (3):32-7. PubMed ID: 15338898
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Preliminary results of initial short-term chemotherapy with INH, RMP and EMB in intermittent and biphasic administration (the 3 plus 6 experiment)].
    Anastasatu C, Bercea O, Barcan F, Stinghe R, Dinulică E, Marcovici M, Cristea M, Cărpinişan L, Gheorghiu M, Iancovici O, Ghinescu S.
    Ftiziologia; 1974 May; 23(3):253-64. PubMed ID: 4842931
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of antituberculosis drugs after oral isolated and simultaneous administration in triple combination.
    Zítková L, Janků I, Tousek J, Papezová E, Stastná J.
    Czech Med; 1983 May; 6(4):202-17. PubMed ID: 6420125
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Rationale for chemotherapy of tuberculosis and current recommendations.
    Kumar L.
    Indian Pediatr; 1992 Nov; 29(11):1337-9. PubMed ID: 1294486
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 68.